Despite advances in the treatment and management of dermatologic conditions such as psoriasis, significant disparities in both treatment and outcomes persist for patients from racial/ethnic underserved groups. Patients of color are not only more likely to present with more severe disease, but they are also more likely to receive either no treatment, or only topical treatments, despite wide availability of effective biologic medications. In fact, Black patients with moderate to severe psoriasis are 70% less likely to receive biologic treatment than their White counterparts. It is imperative that each member of the multidisciplinary care team works together to address these disparities in order to improve equity in treatment and outcomes for all patients.
In this CMEO BriefCase, expert faculty will utilize case-based learning to illustrate these pervasive disparities through the stories of two patients, Miguel and LaToya, while offering strategies to integrate therapies that optimize long-term outcomes and address racial/ethnic inequities in the diagnosis and treatment of patients with psoriasis.
At the conclusion of this activity, learners will be able to better:
Supported by an educational grant provided by Johnson & Johnson.
Physicians specializing in dermatology or primary care, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists
In support of improving patient care, CME Outfitters, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education Credit for learning and change.
CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is designated for 0.75 contact hours.
California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.
This application-based activity is approved for 0.75 contact hours ( 0.075 CEUs) of continuing pharmacy credit ( JA0007185-0000-24-008-H01-P ).
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 01/25/2027. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Dr. Peek reports no financial relationships to disclose.
Dr. Heath reports the following financial relationships:
Advisory Board: Arcutis Biotherapeutics, Inc.; Dermavant Sciences, Inc.; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Johnson & Johnson Consumer Products Company; Pfizer Inc.; Regeneron; Sanofi; Sanofi/ Regeneron Pharmaceuticals Inc.
Consultant: Arcutis Biotherapeutics, Inc.; Avita Medical; L’Oreal USA Inc.
Grants/Research Funding: (paid to institution) Janssen Pharmaceuticals, Inc.
Other financial or material support: WebMD
The following individuals have no financial relationships to disclose:
Marlon (Tony) Graham, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Morgan Stockberger, MD (Planning Committee)
Jessica Whelan, DNP, APRN, FPMHNP-BC, RN-BC (Planning Committee)
Susan H. Yarbrough, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.
Call us at 877.CME.PROS (877.263.7767).
BC-110-012524-57